Maybe. But not yet.
Plenty of twists and turns to come. I was looking to buy under 30c but that hasn't happened (yet).
If I was to guess, I would think that the new majority shareholders would want to see progress. Whilst I agree with Ac8's position as a Pharma for long term success, maybe this might push the buttons to reengage some of the dormant licences and generate a bit of revenue in the short term.
The sniff of revenue from AC8 will create a spike towards $1. It was only a few weeks ago it went over $0.50 on the anticipation of revenue via the then financial release.
Couple revenue with movement on the caps and who knows.
All IMO. DYOR.
- Forums
- ASX - By Stock
- AC8
- News: AC8 Auscann Group Says Canopy Growth Sold Its 13.2% Interest In Co
News: AC8 Auscann Group Says Canopy Growth Sold Its 13.2% Interest In Co, page-5
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AC8 (ASX) Chart |
Day chart unavailable